Mahua Venkatesh retweetledi

From Generics to Biopharma: India’s Pharma Pivot
India, long known as the “pharmacy of the world,” is shifting gears. With initiatives like the Biopharma Shakti Mission, the focus is moving toward high-value biologics and advanced drugs. Backed by FDI push and policy incentives, the sector is evolving beyond low-cost generics. The goal: position India as a global hub for innovation-driven biopharma manufacturing.
Story by @MahuaVenkatesh
#PharmaIndia #Biopharma #FDI #MakeInIndia #HealthcareInnovation #GlobalTrade #IndiaEconomy #Pharmaceuticals #Biologics #IndustryShift
thesecretariat.in/article/pharma…
English


























